Sartor O - Search Results

1

Hermanson T, Sartor O, Ablin RJ, Bennett CL. Hermanson T, et al. Among authors: sartor o. Urology. 2014 Nov;84(5):1072. doi: 10.1016/j.urology.2014.06.068. Epub 2014 Oct 24. Urology. 2014. PMID: 25443906 Free PMC article. No abstract available.

2

Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.

Bennett CL, Ferreira MR, Davis TC, Kaplan J, Weinberger M, Kuzel T, Seday MA, Sartor O. Bennett CL, et al. Among authors: sartor o. J Clin Oncol. 1998 Sep;16(9):3101-4. doi: 10.1200/JCO.1998.16.9.3101. J Clin Oncol. 1998. PMID: 9738581

3

Indium-111-capromab pendetide scans: an important test relevant to clinical decision making.

Sartor O, McLeod D. Sartor O, et al. Urology. 2001 Mar;57(3):399-401. doi: 10.1016/s0090-4295(00)01084-0. Urology. 2001. PMID: 11248605 No abstract available.

4

Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review.

Schmitt B, Wilt TJ, Schellhammer PF, DeMasi V, Sartor O, Crawford ED, Bennett CL. Schmitt B, et al. Among authors: sartor o. Urology. 2001 Apr;57(4):727-32. doi: 10.1016/s0090-4295(00)01086-4. Urology. 2001. PMID: 11306391

5

Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.

Bennett CL, Price DK, Kim S, Liu D, Jovanovic BD, Nathan D, Johnson ME, Montgomery JS, Cude K, Brockbank JC, Sartor O, Figg WD. Bennett CL, et al. Among authors: sartor o. J Clin Oncol. 2002 Sep 1;20(17):3599-604. doi: 10.1200/JCO.2002.11.085. J Clin Oncol. 2002. PMID: 12202660

6

Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect.

Bennett CL, Raisch DW, Sartor O. Bennett CL, et al. Among authors: sartor o. Ann Intern Med. 2002 Oct 1;137(7):625. doi: 10.7326/0003-4819-137-7-200210010-00029. Ann Intern Med. 2002. PMID: 12353966 No abstract available.

7

Eligard: leuprolide acetate in a novel sustained-release delivery system.

Sartor O. Sartor O. Urology. 2003 Feb;61(2 Suppl 1):25-31. doi: 10.1016/s0090-4295(02)02396-8. Urology. 2003. PMID: 12667884

8

An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer.

Sartor O, Dineen MK, Perez-Marreno R, Chu FM, Carron GJ, Tyler RC. Sartor O, et al. Urology. 2003 Aug;62(2):319-23. doi: 10.1016/s0090-4295(03)00330-3. Urology. 2003. PMID: 12893343 Clinical Trial.

9

Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.

Sartor O, Reid RH, Hoskin PJ, Quick DP, Ell PJ, Coleman RE, Kotler JA, Freeman LM, Olivier P; Quadramet 424Sm10/11 Study Group. Sartor O, et al. Urology. 2004 May;63(5):940-5. doi: 10.1016/j.urology.2004.01.034. Urology. 2004. PMID: 15134985 Clinical Trial.

10

Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.

Gandhok N, Sartor O. Gandhok N, et al. Among authors: sartor o. Urology. 2004 Oct;64(4):807-9. doi: 10.1016/j.urology.2004.05.042. Urology. 2004. PMID: 15491730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters